Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 30, Issue 8, 2003, Pages 537-544

  Kumai, Toshio ^a   Oonuma, Shigeko ^a   Kitaoka, Yasushi ^a   Tadokoro, Mamoru ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arteriosclerosis; Hyperlipidaemia; Hypertension; Inbred rats; Lipoprotein

Indexed keywords

ADRENALIN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERLIPIDEMIA; HYPERTENSION; INBRED STRAIN; NONHUMAN; RAT; RISK FACTOR; SPONTANEOUSLY HYPERLIPIDEMIC RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ARTERIES; ARTERIOSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; EPINEPHRINE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERLIPIDEMIAS; HYPERTENSION; LIPOPROTEINS; LIVER; MALE; NOREPINEPHRINE; PEDIGREE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 0042428776     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2003.03872.x     Document Type: Article

References (19)

1. Yamori Y, Murakami S, Nara Y, Ikeda K. Stroke-prone SHR and arteriolipidosis-prone SHR as models for atherosclerosis: Their mechanisms and application for nutritional and pharmacological studies. Clin. Exp. Pharmacol. Physiol. 1995; 1 (Suppl.): S244-55.
2. Okamoto K, Higashizawa T, Miyake H, Ito H, Suzuki T. Establishment of an inbred strain of hypertensive hyper-cholesterolemic rats (hyper T-C rat). Acta Med. Kinki Univ. 1989; 14: 211-27.
3. Higashizawa T. Characteristics of hypertensive hypercholesterolemic rats (hyper T-C rat), a new strain. Acta Med. Kinki Univ. 1989; 14: 229-47.
4. Tobian L, Jahner TM, Johnson MA. Cholesterol ester deposition is reduced in rats with hypercholesterolemia and hypertension. Clin. Exp Hypertens. 1991; 13: 1009-17.
5. Watanabe M, Nakura H, Tateishi T, Tanaka M, Kumai T, Kobayashi S. Reduced hepatic-drug metabolising enzyme activities in spontaneously hyperlipidemic rat as an animal model of hyper-cholesterolaemia. Med. Sci. Res. 1996; 24: 257-9.
6. Okamoto K, Nosaka S, Yamori Y, Matsumoto M. Participation of neural factor in the pathogenesis of hypertension in the spontaneously hypertensive rats. Jpn. Heart J. 1967; 8: 168-80.
7. Brassil PJ, Debri K, Nakura H, Kobayashi S, Davis DS, Edwards RJ. Reduced hepatic expression of CYP7A1 and CYP2C13 in rats with spontaneous hyperlipidemia. Biochem. Pharmacol. 1998; 56: 253-7.
8. Kumai T, Tanaka M, Watanabe M, Nakura H, Kobayashi S. Possible involvement of androgen in increased norepinephrine synthesis in blood vessels of spontaneously hypertensive rats. Jpn. J. Pharmacol. 1994; 66: 439-44.
9. Nagatsu T, Oka K, Kato T. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr. 1979; 163: 247-52.
10. Kumai T, Tanaka M, Tateishi T et al. Effects of anti-androgen treatment on the catecholamine synthetic pathway in the adrenal medulla of spontaneously hypertensive rats. Naunyn Schmiedebergs Arch. Pharmacol. 1998; 357: 620-4.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1978; 162: 156-9.
12. Shimizu H, Kumai T, Kobayashi S. Involvement of tyrosine hydroxylase upregulation in cyclosporine-induced hypertension. Jpn. J. Pharmaol. 2001; 85: 306-12.
13. Yamori Y. Pathogenesis of spontaneous hypertension as a model for essential hypertension. Jpn. Circ. J. 1977; 41: 259-66.
14. Maemura S, Niwa M, Ozaki M. Characteristic alterations in adrenal catecholamine contents in SHR, SHRSP, and WKY during development of hypertension and stroke. Jpn. Heart J. 1982; 23: 593-602.
15. Kumai T, Tanaka M, Watanabe M, Kobayashi S. Elevated tyrosine hydroxylase mRNA levels in the adrenal medulla of spontaneously hypertensive rats. Jpn. J. Pharmacol. 1994; 65: 367-9.
16. Kliewer SA, Willson TM. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnan X receptor. J. Lipid Res. 2002; 43: 359-64.
17. Pullinger CR, Eng C, Salen G et al. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J. Clin. Invest. 2002; 110: 109-17.
18. Day CE, Schurr PE, Phillips WA. Selected animal models for systematic antiatherosclerotic drug development. Adv. Exp. Med. Biol. 1978; 109: 277-83.
19. Joles JA, Willekes-Koolschijn N, van Tol A et al. Hyperlipoproteinemia in one-year-old analbuminemic rats. Atherosclerosis 1991; 88: 35-47.